BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 11, 2021
View Archived Issues
UBE-1099: a novel Keap1-Nrf2 PPI inhibitor for kidney disease
Read More
SUVN-4404091 shows efficacy in rat model of amphetamine-induced hyperlocomotion
Read More
New NMDA receptor antagonists described by Suzhou Nhwa Biomedical Technology
Read More
PharmaBlock Sciences discovers p300 and CREBBP inhibitors
Read More
SyneuRx International patents DAAO and/or 3C-like proteinase inhibitors
Read More
New GnRH-R antagonists identified at Shanghai Innofortune Biotech
Read More
XuanZhu Pharma divulges new DNA-dependent protein kinase inhibitors
Read More
Researchers develop CFTR-mutated cystic fibrosis murine model to allow gene-editing strategies
Read More
TQS-168 extends survival in mouse model of ALS
Read More
Trivalent PROTAC SIM-1 shows enhanced BET degradation and cytotoxicity
Read More
MEF2 as key regulator and potential therapeutic target for neurodegeneration
Read More
Omega Therapeutics offers pipeline and research update
Read More
9 Meters Biopharma and Gustave Roussy collaborate further on gut microbiome modulator NM-102
Read More
Monte Rosa selects MRT-2359 as first development candidate
Read More
Zika-specific therapy found to protect fetal mouse brains
Read More
Virpax announces contracts to support development and manufacturing of Envelta
Read More
Gain reports preclinical data on GT-02287 and GT-02329 for Gaucher's and GBA1 Parkinson's disease
Read More
Lennham discloses deuterated testosterone compound
Read More
BACH1 targeting has neuroprotective effects in Parkinson's disease
Read More
Biomea Fusion advances BMF-219 for leukemia
Read More